163 related articles for article (PubMed ID: 10899669)
1. Genetic aberrations in oral or head and neck squamous cell carcinoma 2: chromosomal aberrations.
Scully C; Field JK; Tanzawa H
Oral Oncol; 2000 Jul; 36(4):311-27. PubMed ID: 10899669
[TBL] [Abstract][Full Text] [Related]
2. Frequent 3p allele loss and epigenetic inactivation of the RASSF1A tumour suppressor gene from region 3p21.3 in head and neck squamous cell carcinoma.
Hogg RP; Honorio S; Martinez A; Agathanggelou A; Dallol A; Fullwood P; Weichselbaum R; Kuo MJ; Maher ER; Latif F
Eur J Cancer; 2002 Aug; 38(12):1585-92. PubMed ID: 12142046
[TBL] [Abstract][Full Text] [Related]
3. Loss of heterozygosity and mutation analysis of the p16 (9p21) and p53 (17p13) genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; López-Larrea C; Suárez C; Menéndez MJ; Coto E
Clin Cancer Res; 1995 Sep; 1(9):1043-9. PubMed ID: 9816078
[TBL] [Abstract][Full Text] [Related]
4. Inactivation of the von Hippel-Lindau (VHL) tumour suppressor gene and allelic losses at chromosome arm 3p in primary renal cell carcinoma: evidence for a VHL-independent pathway in clear cell renal tumourigenesis.
Clifford SC; Prowse AH; Affara NA; Buys CH; Maher ER
Genes Chromosomes Cancer; 1998 Jul; 22(3):200-9. PubMed ID: 9624531
[TBL] [Abstract][Full Text] [Related]
5. Chromosome 3p loss of heterozygosity and mutation analysis of the FHIT and beta-cat genes in squamous cell carcinoma of the head and neck.
González MV; Pello MF; Ablanedo P; Suárez C; Alvarez V; Coto E
J Clin Pathol; 1998 Jul; 51(7):520-4. PubMed ID: 9797729
[TBL] [Abstract][Full Text] [Related]
6. Allelic loss at chromosomes 3p, 8p, 13q, and 17p associated with poor prognosis in head and neck cancer.
Li X; Lee NK; Ye YW; Waber PG; Schweitzer C; Cheng QC; Nisen PD
J Natl Cancer Inst; 1994 Oct; 86(20):1524-9. PubMed ID: 7932807
[TBL] [Abstract][Full Text] [Related]
7. Genetic aberrations in squamous cell carcinoma of the head and neck (SCCHN), with reference to oral carcinoma (review).
Scully C; Field J
Int J Oncol; 1997 Jan; 10(1):5-21. PubMed ID: 21533338
[TBL] [Abstract][Full Text] [Related]
8. Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma.
Szyfter K; Wierzbicka M; Hunt JL; Rinaldo A; Rodrigo JP; Takes RP; Ferlito A
Eur Arch Otorhinolaryngol; 2016 Mar; 273(3):537-45. PubMed ID: 25355032
[TBL] [Abstract][Full Text] [Related]
9. Genetic alterations in head and neck cancer.
Somers KD; Schechter GL
Otolaryngol Clin North Am; 1992 Oct; 25(5):1065-71. PubMed ID: 1408191
[TBL] [Abstract][Full Text] [Related]
10. Definition of three minimal deleted regions by comprehensive allelotyping and mutational screening of FHIT,p16(INK4A), and p19(ARF) genes in nasopharyngeal carcinoma.
Ko JY; Lee TC; Hsiao CF; Lin GL; Yen SH; Chen KY; Hsiung CA; Chen PJ; Hsu MM; Jou YS
Cancer; 2002 Apr; 94(7):1987-96. PubMed ID: 11932901
[TBL] [Abstract][Full Text] [Related]
11. Oncogenes and tumour-suppressor genes in squamous cell carcinoma of the head and neck.
Field JK
Eur J Cancer B Oral Oncol; 1992 Jul; 28B(1):67-76. PubMed ID: 1330149
[TBL] [Abstract][Full Text] [Related]
12. Genetic profile of head and neck squamous cell carcinoma: clinical implications.
Agada FO; Patmore H; Alhamarneh O; Stafford ND; Greenman J
J Laryngol Otol; 2009 Mar; 123(3):266-72. PubMed ID: 18694533
[TBL] [Abstract][Full Text] [Related]
13. Definition of a tumor suppressor gene locus on the short arm of chromosome 3 in squamous cell carcinoma of the head and neck by means of microsatellite markers.
Rowley H; Jones A; Spandidos D; Field J
Arch Otolaryngol Head Neck Surg; 1996 May; 122(5):497-501. PubMed ID: 8615966
[TBL] [Abstract][Full Text] [Related]
14. Genome-wide analysis of recurrent copy-number alterations and copy-neutral loss of heterozygosity in head and neck squamous cell carcinoma.
Marescalco MS; Capizzi C; Condorelli DF; Barresi V
J Oral Pathol Med; 2014 Jan; 43(1):20-7. PubMed ID: 23750501
[TBL] [Abstract][Full Text] [Related]
15. INK4a-ARF alterations and p53 mutations in primary and consecutive squamous cell carcinoma of the head and neck.
Weber A; Bellmann U; Bootz F; Wittekind C; Tannapfel A
Virchows Arch; 2002 Aug; 441(2):133-42. PubMed ID: 12189502
[TBL] [Abstract][Full Text] [Related]
16. Allelic loss correlated with tissue specificity in head and neck squamous cell carcinomas and the clinical features of patients.
Shiga K; Matsuura K; Tateda M; Saijo S; Ogawa T; Miyagi T; Kobayashi T
Tohoku J Exp Med; 2004 Oct; 204(2):163-72. PubMed ID: 15383697
[TBL] [Abstract][Full Text] [Related]
17. Genetic alterations in head and neck squamous cell carcinomas.
Nagai MA
Braz J Med Biol Res; 1999 Jul; 32(7):897-904. PubMed ID: 10454750
[TBL] [Abstract][Full Text] [Related]
18. Allelic loss and tumor pathology in head and neck squamous cell carcinoma.
Rybicki BA; Savera AT; Gomez JA; Patel SC; Ballard NE; Benninger MS; Zarbo RJ; Van Dyke DL
Mod Pathol; 2003 Oct; 16(10):970-9. PubMed ID: 14559979
[TBL] [Abstract][Full Text] [Related]
19. Clinical applications of the diagnosis of p53 alterations in squamous cell carcinoma of the head and neck.
Lopez-Martinez M; Anzola M; Cuevas N; Aguirre JM; De-Pancorbo M
Med Oral; 2002; 7(2):108-20. PubMed ID: 11887018
[TBL] [Abstract][Full Text] [Related]
20. Molecular characterization of head and neck tumors by analysis of telomerase activity and a panel of microsatellite markers.
Fiedler W; Hoppe C; Schimmel B; Koscielny S; Dahse R; Bereczki Z; Claussen U; Ernst G; von Eggeling F
Int J Mol Med; 2002 Apr; 9(4):417-23. PubMed ID: 11891539
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]